Drew is Co-Founder and CEO at Acorn Biolabs. He has a diverse background including biomedical engineering and molecular biology, healthcare venture investing, and professional athletics. He completed his undergrad in Biology at the University of Michigan and a Masters from the same school in Molecular, Cellular, & Developmental Biology. He also completed his PhD with the University of Toronto in Biomedical Engineering while playing professional minor league baseball as a pitcher for both the Toronto Blue Jays and the Philadelphia Phillies. Prior to joining Acorn, Drew spent several years as Chief Science Officer at the venture capital firm Epic Capital Management finding, funding and advising start-ups in the medtech community. Prior to that he was part of the Mount Sinai Hospital Bioengineering of Skeletal Tissues Team. Drew has been widely published across international medical journals with specific focus on tissue engineering and sports medicine. Recently, Drew’s talk on regenerative medicine & genetics was featured at Collision, MaRS Health Innovation Week, Big Data AI Toronto as well as at Elevate Tech Fest. Drew's current mandate is to lead Acorn Biolabs to market to bring accessible, non-invasive and affordable live cell collection and preservation to consumers everywhere.